Obamacare, speculate about the emerging Republican replacement plan and provide context to the evolving debate based on data-driven fundamentals of healthcare delivery. Likely "winners and losers" by stakeholder are also identified. Whatever the outcome of PPACA "repeal and replace," we believe that another reform debate, focused solely on health insurance coverage and payment for such coverage, will not adequately address the root cause of rising healthcare costs and attendant rises in health insurance premiums, i.e., an inefficient and ineffective care delivery system that on an age-adjusted per capita basis is 50% to 75% more expensive than that of other Organization for Economic Co-operation and Development (OECD) nations.
Changes to the PPACA will not occur overnight. The legislation contains 2,700 pages; associated regulations represent another 20,202 pages. 1 It is important to recognize that government involvement in the large and often dysfunctional U.S. healthcare delivery system has been longstanding since the inception of Medicare and Medicaid in 1965. 5 The PPACA represents only one step, albeit an important one, in the evolution of care delivery. Any changes to the PPACA by the new Congress and Trump administration will represent the next iteration.
Prudent public policy formation would suggest that any repeal and replacement of the PPACA should take into account those provisions that have succeeded and those that have failed. Below we have attempted to provide a fact-based rationale for grading the impact of the PPACA on expanding healthcare insurance coverage and cost containment. We also grade access and affordability, variables that are intimately related to the implied benefit associated with insurance coverage.
The essence of Obamacare is coverage; the number of uninsured Americans declined by 35% from 41.0 to 28.5 million in 2013 to 2015. This number is forecast to fluctuate no more than +/-2 million by 2025, assuming no legislative or regulatory changes. The Commonwealth Fund has developed a Health Care Affordability Index based on premium, deductible and out-of-pocket costs. One-quarter of all privately insured adults have high healthcare cost burdens. In a 2015 survey, 26% of Americans described healthcare costs as causing a serious financial problem during the prior two years, 27%
describe being unable to pay for basic necessities like food, heat or housing, and 42% mention spending all or most of their personal savings. 10 Healthcare costs are a major contributor, if not the leading factor, associated with personal bankruptcy. The celebration was premature and factually incorrect. Factors such as the Great Recession, significant cost shifting by employers and continued generic drug penetration led to the slowdown in healthcare spending; net structural changes instituted by the PPACA were inconsequential. In actuality, value-based CMS initiatives were more than offset by increased coverage, provider and insurer consolidation, and explosive growth in specialty and branded drug pharmaceutical pricing, thereby setting the stage for an acceleration of healthcare spending.
In 2014, overall health spending grew by 5.3%, whereas per capita spending increased by 4.4% (Figure 3 ). The comparable figures for 2015 were 5.8 and 5.0%, respectively. 13
The latest projections from CMS forecast even higher growth through 2025. (Table 1 ):
• Managing competition: Consolidation, as measured by standard measures of competition such as the Herfindahl-Hirschman Index (HHI), leads to higher baseline prices and portends a higher rate of spending growth in the future.
• Increasing clinical effectiveness: Defined as the application of the best knowledge, derived from research, clinical experience and patient preferences to achieve optimum processes and outcomes of care for patients. Systematic reviews-the basis of evidence-based medicine-can show which treatments and prevention methods have been proven to work and what remains unknown.
• Improving efficiency: A measure of the relationship between a specific level of healthcare quality and the resources (intensity) used to provide that care, i.e., the production of the desired effects or results with minimum waste of time, effort or skill.
• Facilitating payment reform: Involves the use of financial incentives and disincentives to facilitate the transition from fee-for-service (FFS) payment models-providers receiving a specific amount of compensation in exchange for providing a patient with a specific service-to value-based payment systems focused on the provision of high-quality, efficient care.
• Enhancing the experience of care: Reflects occurrences and events that happen independently and collectively across the continuum of care. Embedded within patient experience is setting expectations, focusing on the specific needs of individual patients, and engaging patients and their caregivers. In all of these areas, the record is mixed, if not overall negative. In large part, the PPACA has led to a consolidation of providers and payers, with resultant increased prices.
PPACA initiatives have shown only modest impact on clinical outcomes and overall improvements in the health of the general population. Although the PPACA created some new payment models (Accountable Care Organizations) and furthered Medicare's value-based purchasing initiatives, the record on improving efficiency or payment models is negative to mixed. Finally, preliminary data suggests that the PPACA has not increased overall patient / consumer satisfaction with the healthcare delivery system. 
